Follow the hVIVO plc share price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares are listed on the UK market, under the supervision of RNS (LSE). Market capitalisation: €45.4m. The latest transaction was disclosed on 24 April 2026 (Sale). Among the most active insiders: Brendan Buckley. All data is accessible without an account.
4
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Fundamental score
Ranked 26,979 of 29,063 companies
18.6
score / 100
Value
7
Quality
30
FCF yld-35%
Earn yld-13%
EV/EBITDA50.3x
ROE-14%
Gross mgn77%
Net mgn-13%
Debt/EBITDA12.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
0Option exercise: Outside a trading venue Sale: London Stock Exchange, AIM Market (XLON)ISINISIN GB00B9275X97RNS:5564770
4 of 4 declarations
Acerca de hVIVO plc
hVIVO plc es una empresa con sede en el Reino Unido centrada en el desarrollo de tratamientos para enfermedades respiratorias e infecciosas. Se especializa en ensayos clínicos y estudios de desafío humano.